Clinical Trial Update: Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating RAD001 (everolimus) for growth of vestibular schwannomas in Neurofibromatosis type 2; the study has completed and reported efficacy and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type 2

Drugs mentioned

• Everolimus (RAD001) (everolimus)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Neurofibromatosis 2 | Phase 2 | Status: COMPLETED